Research Briefs

One of the tricky aspects of HIV drug therapy is determining just how well the drugs have worked. The HIV DNA (provirus) in resting cells is usually too defective to replicate itself the way intact proviruses can. But most current tests can’t tell the difference between the two. Now, however, researchers from Johns Hopkins University have developed an accurate and scalable assay to easily count the cells in the HIV reservoir